{"id":69591,"date":"2026-07-08T14:11:10","date_gmt":"2026-07-08T06:11:10","guid":{"rendered":"https:\/\/flcube.com\/?p=69591"},"modified":"2026-07-08T14:11:11","modified_gmt":"2026-07-08T06:11:11","slug":"hanx-biopharmaceuticals-partners-with-hust-cityu-macau-institute-to-establish-ai-driven-drug-discovery-joint-laboratory","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=69591","title":{"rendered":"Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Hanx Biopharmaceuticals (Wuhan) Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/3378:HKG\">HKG: 3378<\/a>) announced the formal establishment of a <strong>Joint Laboratory for Artificial Intelligence-Driven Drug Discovery<\/strong> in partnership with the <strong>Advanced Interdisciplinary Research Centre of the HUST-CityU Macau Institute of Advanced Studies<\/strong>. The collaboration combines the research center&#8217;s <strong>AI platform capabilities<\/strong> with Hanx&#8217;s <strong>innovative drug R&amp;D expertise<\/strong> to accelerate antibody discovery and molecular design.<\/p>\n\n\n\n<h2 id=\"h-partnership-framework-amp-strategic-objectives\" class=\"wp-block-heading\">Partnership Framework &amp; Strategic Objectives<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Parties<\/strong><\/td><td>Hanx Biopharmaceuticals \/ HUST-CityU Macau Institute<\/td><\/tr><tr><td><strong>Agreement<\/strong><\/td><td>Cooperation Agreement for Joint Laboratory Establishment<\/td><\/tr><tr><td><strong>Focus Areas<\/strong><\/td><td>1. AI-assisted antibody optimization<br>2. Intelligent molecular design and development<\/td><\/tr><tr><td><strong>Technology Integration<\/strong><\/td><td>HUST AI platform + Hanx drug discovery expertise<\/td><\/tr><tr><td><strong>Primary Goals<\/strong><\/td><td>Optimize screening workflows, enhance R&amp;D efficiency, accelerate FIC\/BIC development<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>7 July 2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-technology-synergies-amp-innovation-strategy\" class=\"wp-block-heading\">Technology Synergies &amp; Innovation Strategy<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI-Assisted Antibody Optimization<\/strong>: Leveraging advanced machine learning algorithms to predict antibody-antigen binding affinity, stability, and developability properties, significantly reducing experimental screening requirements and accelerating lead candidate identification.<\/li>\n\n\n\n<li><strong>Intelligent Molecular Design<\/strong>: Utilizing generative AI models and computational chemistry approaches to design novel molecular entities with optimized pharmacokinetic, pharmacodynamic, and safety profiles from first principles.<\/li>\n\n\n\n<li><strong>Integrated Workflow Enhancement<\/strong>: The joint laboratory will implement end-to-end AI-driven pipelines that seamlessly integrate target validation, hit identification, lead optimization, and preclinical candidate selection, creating a unified digital drug discovery ecosystem.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The partnership represents a strategic shift toward <strong>computational-first drug discovery<\/strong>, enabling Hanx to compete with global pharmaceutical leaders in developing <strong>first-in-class (FIC)<\/strong> and <strong>best-in-class (BIC)<\/strong> therapeutics across multiple disease areas.<\/p>\n\n\n\n<h2 id=\"h-operational-impact-amp-development-efficiency\" class=\"wp-block-heading\">Operational Impact &amp; Development Efficiency<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Cycle Time Reduction<\/strong>: AI-driven predictive modeling is expected to compress traditional discovery timelines by <strong>40-60%<\/strong>, enabling faster progression from target identification to clinical candidate selection.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Cost Optimization<\/strong>: Reduced experimental screening requirements and improved success rates at each development stage could lower overall R&amp;D costs by <strong>25-35%<\/strong> while maintaining or improving compound quality.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Success Rate Enhancement<\/strong>: Machine learning models trained on Hanx&#8217;s proprietary biological and chemical datasets will improve the probability of technical and clinical success, addressing the industry-wide challenge of high attrition rates in drug development.<\/p>\n\n\n\n<h2 id=\"h-strategic-positioning-amp-competitive-landscape\" class=\"wp-block-heading\">Strategic Positioning &amp; Competitive Landscape<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Academic-Industry Bridge<\/strong>: The collaboration exemplifies the growing trend of biopharmaceutical companies partnering with academic AI research centers to access cutting-edge computational capabilities without significant internal infrastructure investment.<\/li>\n\n\n\n<li><strong>China AI Leadership<\/strong>: The partnership leverages China&#8217;s substantial investments in AI research and talent development, positioning Hanx at the forefront of the country&#8217;s emerging AI-driven biotechnology ecosystem.<\/li>\n\n\n\n<li><strong>Global Competitiveness<\/strong>: Enhanced computational capabilities enable Hanx to pursue complex, high-value targets that were previously considered undruggable or commercially unviable due to development complexity.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking information regarding research collaborations, technology integration, and development efficiency improvements. Actual results may differ due to technical challenges, regulatory requirements, competitive developments, and market conditions.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/07\/2026070701545_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2026070701545_c.\"><\/object><a id=\"wp-block-file--media-f02da95a-05d0-4a30-8e05-730b6c95b438\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/07\/2026070701545_c.pdf\">2026070701545_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/07\/2026070701545_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-f02da95a-05d0-4a30-8e05-730b6c95b438\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG: 3378) announced the formal establishment of a Joint Laboratory&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10,93],"tags":[99,2333,4503],"class_list":["post-69591","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","category-digital","tag-ai","tag-hanx-biopharmaceuticals","tag-hkg-3378"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG: 3378) announced the formal establishment of a Joint Laboratory for Artificial Intelligence-Driven Drug Discovery in partnership with the Advanced Interdisciplinary Research Centre of the HUST-CityU Macau Institute of Advanced Studies. The collaboration combines the research center&#039;s AI platform capabilities with Hanx&#039;s innovative drug R&amp;D expertise to accelerate antibody discovery and molecular design.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=69591\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory\" \/>\n<meta property=\"og:description\" content=\"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG: 3378) announced the formal establishment of a Joint Laboratory for Artificial Intelligence-Driven Drug Discovery in partnership with the Advanced Interdisciplinary Research Centre of the HUST-CityU Macau Institute of Advanced Studies. The collaboration combines the research center&#039;s AI platform capabilities with Hanx&#039;s innovative drug R&amp;D expertise to accelerate antibody discovery and molecular design.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=69591\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-08T06:11:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-08T06:11:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69591#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69591\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory\",\"datePublished\":\"2026-07-08T06:11:10+00:00\",\"dateModified\":\"2026-07-08T06:11:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69591\"},\"wordCount\":467,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AI\",\"Hanx Biopharmaceuticals\",\"HKG: 3378\"],\"articleSection\":[\"Company\",\"Deals\",\"Digital\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=69591#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69591\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=69591\",\"name\":\"Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-07-08T06:11:10+00:00\",\"dateModified\":\"2026-07-08T06:11:11+00:00\",\"description\":\"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG: 3378) announced the formal establishment of a Joint Laboratory for Artificial Intelligence-Driven Drug Discovery in partnership with the Advanced Interdisciplinary Research Centre of the HUST-CityU Macau Institute of Advanced Studies. The collaboration combines the research center's AI platform capabilities with Hanx's innovative drug R&D expertise to accelerate antibody discovery and molecular design.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69591#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=69591\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=69591#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory - Insight, China&#039;s Pharmaceutical Industry","description":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG: 3378) announced the formal establishment of a Joint Laboratory for Artificial Intelligence-Driven Drug Discovery in partnership with the Advanced Interdisciplinary Research Centre of the HUST-CityU Macau Institute of Advanced Studies. The collaboration combines the research center's AI platform capabilities with Hanx's innovative drug R&D expertise to accelerate antibody discovery and molecular design.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=69591","og_locale":"en_US","og_type":"article","og_title":"Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory","og_description":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG: 3378) announced the formal establishment of a Joint Laboratory for Artificial Intelligence-Driven Drug Discovery in partnership with the Advanced Interdisciplinary Research Centre of the HUST-CityU Macau Institute of Advanced Studies. The collaboration combines the research center's AI platform capabilities with Hanx's innovative drug R&D expertise to accelerate antibody discovery and molecular design.","og_url":"https:\/\/flcube.com\/?p=69591","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-07-08T06:11:10+00:00","article_modified_time":"2026-07-08T06:11:11+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=69591#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=69591"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory","datePublished":"2026-07-08T06:11:10+00:00","dateModified":"2026-07-08T06:11:11+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=69591"},"wordCount":467,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AI","Hanx Biopharmaceuticals","HKG: 3378"],"articleSection":["Company","Deals","Digital"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=69591#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=69591","url":"https:\/\/flcube.com\/?p=69591","name":"Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-07-08T06:11:10+00:00","dateModified":"2026-07-08T06:11:11+00:00","description":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG: 3378) announced the formal establishment of a Joint Laboratory for Artificial Intelligence-Driven Drug Discovery in partnership with the Advanced Interdisciplinary Research Centre of the HUST-CityU Macau Institute of Advanced Studies. The collaboration combines the research center's AI platform capabilities with Hanx's innovative drug R&D expertise to accelerate antibody discovery and molecular design.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=69591#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=69591"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=69591#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Hanx Biopharmaceuticals Partners with HUST-CityU Macau Institute to Establish AI-Driven Drug Discovery Joint Laboratory"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69591","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=69591"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69591\/revisions"}],"predecessor-version":[{"id":69593,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/69591\/revisions\/69593"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=69591"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=69591"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=69591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}